本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
TAIPEI, May 13, 2025 /PRNewswire/ -- Dr.AI (https://www.draiai.com/), an AI medical platform designed for healthcare professionals, has been honored with the 2025 COMPUTEX "Best Choice Award – Digital Healthcare Category" for its groundbreaking applications and outstanding performance in streamlining clinical pathways across both inpatient and outpatient care. Dr.AI integrates AI-driven tools such as Medical Pre-Assessment (MedPA), real-time speech-to-text (STT) transcription, and automated SOAP note generation to address the heavy burden of clinical documentation and resolve key blind spots in care delivery. The platform improves clinical productivity, accelerates smart hospital transformation, and showcases Taiwan's leadership in AI-driven healthcare innovation. Dr.AI (https://www.draiai.com) MedPA & SOAP Note: Smart Tools for Clinical Upgrade A major highlight of Dr.AI's award-winning capabilities is the MedPA (Medical Pre-Assessment) feature, a physician-avatar system co-developed by IntoWell Biomedical Technology and Gemtek Technology. During onsite check-in or online scheduling, patients can interact with the "MoAI Avatar" to describe symptoms, which are automatically recorded and transcribed into a SOAP note. This note is transmitted in real time to the physician's workstation. It empowers clinicians with pre-consult insights that significantly reduce consultation time and improve workflow efficiency. In the consultation room, physicians no longer need to manually document notes. Dr.AI's built-in SOAP QuickNote feature uses speech-to-text (STT) technology to transcribe real-time conversations and instantly generate structured SOAP medical records. This reduces documentation workload by over 70% and ensures accuracy and consistency in patient records. Clinical Adoption, System Integration, and Global Expansion The platform has already been successfully adopted by major hospitals, primary care clinics, and health examination centers across Taiwan. Integration with Taiwan's three leading HIS vendors is now underway, with plans to scale to thousands of clinics nationwide. Internationally, expansion is progressing across Japan, Korea, and Singapore, while a newly signed MOU with a major healthcare park in the Middle East sets the stage for cross-border smart hospital collaborations. Clarence Liao, M.D., founder of Dr.AI and CEO of IntoWell Biomedical Technology, stated:"Our mission is to build an AI medical platform that truly aligns with clinical needs. Dr.AI is designed to reduce the burden on healthcare professionals, support cross-border care, and elevate the global standard of medical service delivery. This award marks a pivotal milestone for Taiwan's AI healthcare innovation on the international stage." Comprehensive, Real-Time Support for Clinical Applications Dr.AI is deeply embedded in both inpatient and outpatient care. It supports physicians through automated documentation of Admission Notes, Progress Notes, SOAP Notes, Nursing Notes, discharge planning, and pre-consult assessments. For health examination centers, Dr.AI's MedExam Pro generates over 100 comprehensive reports in just 15 minutes. Expanding AI Care Beyond Clinical Settings Beyond clinical use, Dr.AI is extending into broader public health. At COMPUTEX, IntoWell and Gemtek jointly unveiled the Dr.AI Smart Ring, a wearable device powered by the Dr.AI medical engine. Users can interact with a virtual AI doctor to receive spoken health insights and video consultations, making it easier to understand physiological conditions without having to interpret complex data. Additionally, Dr.AI is entering veterinary healthcare with the launch of Vet.AI in May. This 24/7 AI veterinary consultation platform offers voice-interactive care, pet profile memory, and disease prevention guidance, bringing professional-grade care to pet owners at any time. With its expanding ecosystem and AI-driven innovations, Dr.AI is redefining how smart hospitals operate and setting new benchmarks for accessible, efficient, and intelligent global healthcare.
NCKUH embraces digitization, revolutionizing patient care through technologyTAIPEI, TAIWAN - Media OutReach Newswire - 8 January 2025 - Smart hospitals are at the forefront of a global transformation in healthcare, integrating advanced technologies to improve patient outcomes, enhance operational efficiency, and reduce costs. By leveraging innovations such as artificial intelligence, wearable devices, telehealth services, and big data analytics, smart hospitals are addressing critical challenges in the healthcare ecosystem and setting new benchmarks for excellence. The Role of Smart Hospitals in Modern Healthcare Smart hospitals represent the convergence of technology and medicine, offering a seamless and patient-centric approach to care. These facilities optimize processes and integrate data to provide: Cost Reduction and Operational Excellence: Digitized workflows and automated processes minimize inefficiencies and streamline care delivery. Better Patient Management: Remote patient monitoring systems and AI-driven tools enable timely interventions and better health outcomes. Patient Empowerment and Access: Borderless hospital models extend care beyond traditional settings, offering virtual consultations and tailored treatment plans. For further information, download our complimentary white paper here. "The transition to smart hospitals is not just a trend—it's a necessity," noted Sowmya Srinath, Consulting Director, Healthcare and Lifesciences at Frost & Sullivan. "As global healthcare systems face mounting pressures, from rising costs to aging populations, smart hospitals provide a sustainable solution by integrating technology to enhance efficiency, improve patient outcomes, and make care more accessible." NCKUH: A Leading Example of Smart Hospital Innovation National Cheng Kung University Hospital (NCKUH) in Taiwan exemplifies the transformative power of smart hospitals. NCKUH has consistently strived to embrace modernity while staying true to the founding principle of medicine: delivering quality care. Its innovations include: 1. Smart Examination Transfer System This platform enables direct digital referrals between primary care providers and hospitals, lowering costs, and improving care coordination. 2. Stroke Patient Management NCKUH’s web-based Endovascular Thrombectomy Transfer System has decreased stroke patient transfer times in the Tainan region to 77 minutes, significantly enhancing the likelihood of recovery and functional outcomes. 3. Smart Geriatric Rehabilitation System Using wearable technology, NCKUH provides personalized rehabilitation for frail patients, reducing fall risks and improving overall health outcomes. "Smart hospitals are more than just a technological upgrade—they represent a paradigm shift in how healthcare is delivered," said Dr. Lee Jing-Wei, superintendent of National Cheng Kung University Hospital. "At NCKUH, we're proud to lead the way by leveraging cutting-edge tools to enhance outcomes, streamline operations, and ultimately provide better care for our patients." As healthcare systems worldwide grapple with rising costs and growing demand, smart hospitals offer a sustainable and scalable solution. By driving operational efficiency, reducing the burden on resources, and improving care accessibility, these facilities are shaping the future of global healthcare. Hashtag: #NCKUH #SmartHospital The issuer is solely responsible for the content of this announcement.About National Cheng Kung University HospitalNational Cheng Kung University Hospital (NCKUH) is a leading medical center in southern Taiwan. We uphold the core values of Life, Love, Excellence, and Innovation, and are dedicated to healthcare service, teaching and research. NCKUH strives to be the premier healthcare destination for the public and a nurturing environment for medical professionals.About Frost & SullivanFor over six decades, Frost & Sullivan has helped build sustainable growth strategies for Fortune 1000 companies, governments, and investors. We apply actionable insights to navigate economic changes, identify disruptive technologies, and formulate new business models to create a stream of innovative growth opportunities that drive future success. Contact us: Start the discussion.
TIANJIN, China, June 27, 2025 /PRNewswire/ -- From June 24 to 26, the World Economic Forum 2025 Annual Meeting of the New Champions (the 16th Summer Davos Forum) was held in Tianjin. Artificial intelligence, as the new frontier of global economic growth, was one of the hottest topics of this year's forum. Dialogue on the Theme of "AI+ Era" Ms. Gong Rujing (Gong Yingying), Founder and Chairwoman of Yidu Tech, was invited to attend the forum as a representative of the AI healthcare industry and a Young Global Leader. She delivered insightful remarks in the themed dialogue "The AI+ Era", sharing the stage with Dr. Peter Koerte, Member of the Managing Board, Chief Technology Officer and Chief Strategy Officer of Siemens AG; Zhu Min, Senior Fellow at the China Center for International Economic Exchanges and former Deputy Managing Director of the International Monetary Fund; and Kenny Lam, CEO Asia Pacific at Two Sigma. The dialogue was moderated by Azeem Azhar, CEO of Exponential View. Yidu's Healthcare Innovation Practice: From Data Intelligence Infrastructure to AI Clinical Implementation Gong Rujing (Gong Yingying) pointed out that the trend of population aging poses a severe challenge to healthcare systems: "The original intention of founding Yidu Tech ten years ago was based on the foresight that the traditional healthcare supply chain would be unsustainable under the aging peak expected by 2030." She emphasized that the core prerequisite for the implementation of AI in the medical field is to overcome the challenge of unstructured medical data. Over the past ten years, Yidu Tech has invested considerable resources in promoting data standardization governance, making it truly computable and applicable. The company's core algorithm engine, YiduCore, has cumulatively and legally processed and analyzed over 6 billion medical records—this is the foundational resource enabling AI technology to deeply empower healthcare. With the breakthrough progress in large model technology, Yidu Tech's years of medical data governance capabilities are generating exponential value—the company has not only independently developed a large language model in the medical domain but also launched a Clinical-Grade Intelligence Engine "AI Middleware Platform" to drive the construction of smart hospitals, successfully implemented in over 30 well-known top-tier hospitals within three months. "At present, each doctor handles 30 to 100 patient visits per day. The AI Middleware Platform is deeply integrated into the entire diagnosis and treatment process as doctors' 'AI Copilot Station', continuously empowering pre-diagnosis information integration, in-consultation decision support, and post-diagnosis patient management, thereby reducing doctors' burdens." In the pre-diagnosis phase, the intelligent pre-consultation system collects patients' chief complaints, medical history, medication information, etc., through natural language interaction, improving the density of valid information. Particularly noteworthy is the intelligent medical record generation function, which can integrate the patient's pre-consultation information, consultation recording, and historical data (examinations/imaging/past records, etc.) with one click to generate a preliminary medical record, significantly reducing doctors' workload. In the in-consultation phase, AI can parse patients' past medical records within seconds, dynamically generate a timeline and trend charts of patients' treatment history to help doctors quickly understand key medical history. AI also comprehensively considers diagnostic data and marks the basis for decisions, effectively supporting clinical decision-making while ensuring scientific rigor and reliability. In the post-diagnosis phase, the AI patient management platform enables data interconnectivity within and outside the hospital. Based on specialized large language models, it provides personalized follow-up, rehabilitation guidance, and medication guidance services to improve patient compliance. "This not only frees up doctors' time but also significantly improves the quality of diagnosis and treatment and patient experience through precision data-driven methods," said Gong Rujing (Gong Yingying). From February to June 2025, the AI diagnosis and treatment assistant built on the AI Middleware Platform assisted doctors in serving a total of 26,000 patients. Human-Machine Collaboration: From Medical Empowerment to Organizational Evolution Gong Rujing (Gong Yingying) believes that current AI development is still in its early stage, and its ultimate form has not yet taken shape. Therefore, Yidu Tech maintains an open mindset and takes "creating real value in end-user scenarios" as the core anchor of its AI strategy. She emphasized: "The key to harnessing AI lies not only in the technology itself but also in achieving deep collaboration between humans and technology." This concept is deeply reflected in Yidu Tech's innovation in medical practice. The pain point of traditional AI healthcare lies in the attempt to use standardized tools to meet the diverse needs of doctors. However, uniformly built models or applications cannot meet the stringent requirements of specialists for professional depth, nor can they flexibly adapt to the specific work scenarios of doctors with different levels of seniority and positions. To solve this contradiction, Yidu Tech launched the "Custom Smart Assistant" function on top of the AI Middle Platform, allowing doctors to independently design intelligent assistants tailored to their unique needs through zero-code, "Lego-style" modular construction. This is a key step for AI in healthcare to move toward deeply contextualized scenarios and marks a shift from the previous "tool-based empowerment" to doctor-led "co-creation of capabilities". AI tools developed by doctors themselves will become a key force in enhancing the accessibility of medical services. At the same time, the concept of human-machine collaboration is also driving the internal organizational evolution of Yidu Tech. "During periods of rapid technological iteration, an organization's learning capacity, resilience to change, and value orientation are more important than a single technological advantage." Gong Rujing (Gong Yingying) actively advocates that the team embrace AI transformation, maintain high adaptability, and form an efficient collaborative working relationship with AI agents. Currently, AI agents have taken on about 20% of Yidu Tech's daily work. This is not only an improvement in efficiency but also a substantive manifestation of the organizational form and work paradigm moving toward "human-machine symbiosis." "Data privacy, cross-institution collaboration, and technological ethics are common challenges faced by AI healthcare development worldwide. However, the large-scale application scenarios of China's healthcare system provide a unique advantage for AI technology iteration." In the global tide of accelerating toward an intelligent era, Gong Rujing (Gong Yingying)'s sharing at the Summer Davos Forum showcased the innovation strength of AI healthcare enterprises and offered a practical path for the industry's development. As "AI + Healthcare" evolves from concept to deep implementation, Yidu Tech will remain grounded in data and empowered by AI, continuously exploring new possibilities and driving the healthcare industry toward greater efficiency, precision, and accessibility.
The latest funding round will fuel Weimai's efforts to expand its full-cycle healthcare solutions, leveraging AI and digital tools to provide comprehensive care across China HANGZHOU, China, Jan. 7, 2025 /PRNewswire/ -- Weimai, a leading provider of one-stop digital healthcare solutions in China, has completed a Series D funding round, raising 200 million yuan ($27.3 million). A bird's eye view of Weimai's headquarters in Hangzhou. The funds will support the expansion of its comprehensive healthcare services aimed at meeting the growing demand for long-term, full-cycle medical care. The latest funding round roped in new investors including CNCB INVESTMENT, CHOICE CAPITAL, Yuhang Transformation Industry Investment, Deqing Industry Development Investment, and Nanhu Investment. Existing shareholders Source Code Capital, Cenova Ventures, and Vision+ Capital also participated in this round. The proceeds will be used to step up Weimai's development of disease management solutions and AI-related research. Founded in 2015, Weimai has become China's largest online full-cycle healthcare management platform, addressing the need for continuous health services via its proprietary business model of "managed care organization" (MCO). Qiu Jialin, founder and CEO of Weimai, commented, "MCO is a new concept in China. Over the past nine years, we have consistently integrated MCO with the practices of China's healthcare reforms, pioneering a uniquely Chinese approach to managed care—C-MCO." "Through technological empowerment, we have upgraded healthcare services to provide full-cycle management and closed-loop services across pre-hospital, in-hospital, and post-hospital scenarios," Qiu added. Under this model, Weimai focuses on addressing the extensive and diverse service needs for post-diagnosis, post-test, post-surgery, post-hospitalization medication, follow-up consultations, diet, exercise, and rehabilitation. Revolving around patient needs, Weimai provides integrated healthcare management services that combine online and offline, in-hospital and out-of-hospital care, covering the full spectrum of pre-hospital, in-hospital, and post-hospital scenarios. This service model significantly enhances the efficiency and quality of healthcare services while also improving patients' medical experience and recovery outcomes. Fang Sheng, Head of the Financing Division of CNCB INVESTMENT, noted, "the continuously expanding business landscape and improving financial performance over the past three years reflect the mature management capabilities of Weimai's team. We look forward to Weimai continuing to advance on this long and challenging path." Chen Du, investment manager at Yuhang Transformation Industry Investment, said, "amid the wave of digital healthcare, Weimai's business model stands out. It precisely targets its development direction, deeply integrates digital technology with medical services, and significantly drives the upgrading of healthcare consumption. We firmly believe that Weimai will continue to lead industry transformation and open up a broader future for public health." As of December 31, 2024, Weimai has connected with over 2,500 public healthcare institutions and 200,000 licensed doctors nationwide, serving a cumulative billion patients. Central to Weimai's offerings is its pre-trained AI model, CareAI, which automates health assessments and self-screenings, enhancing triage and referral processes. Launched in 2023, CareAI also enables efficient data retrieval for doctors and integrates with platforms like hospital apps and WeChat, offering multi-format health management advice throughout the care process. With rising per capita disposable income, an aging population, and growing health awareness, the demand for quality healthcare services continues to grow in China. Against this backdrop, expanding the supply of healthcare services and extending the reach of healthcare services have become essential to the development of China's healthcare system. As a frontrunner in this trend, Weimai integrates ecosystem resources and incorporates commercial insurance into its management services, creating a closed-loop "healthcare-pharmaceutical-insurance" service model. This approach strengthens proactive disease management and enhances the patient service experience, enabling residents in lower-tier regions to access comprehensive health management services spanning prevention, diagnosis, treatment, and rehabilitation. With a vision to create "smart hospitals without walls," Weimai is dedicated to providing comprehensive, personalized and long-term healthcare services to meet the evolving needs of the public and align with China's national health strategy. About Weimai A pioneer in digital full-cycle healthcare management, Weimai has become China's largest platform in this sector. Leveraging its proprietary CareAI technology, Weimai has been driving the large-scale adoption of comprehensive care management solutions since 2015.
Hsinchu, Taiwan, December 5, 2024 – ACE Biotek, in collaboration with Shin Kong Wu Ho-Su Memorial Hospital, proudly at the 2024 Taiwan Healthcare Expo. Under the theme “Generative AI Driving Medical Innovation, ESG Leading the Future of Health,” the event highlighted achievements in intelligent healthcare and sustainable development. Since signing an MOU in 2023, the partnership has focused on developing and applying the Spark Surgical Anesthesia System and the EP100 Ophthalmology Recording System (EaglePark100). Interactive on-site demonstrations attracted numerous medical professionals. The opening day featured key leadership figures from Shin Kong Wu Ho-Su Memorial Hospital, including Chairman Eugene Wu, Superintendent Sheng-Mao Hou, and Vice Superintendent Tzu-Jen Hung, engaging with attendees. Dr. Nina Kao, Executive Director of Changhua Christian Hospital's Overseas Medical Mission Center, led a delegation of 30 hospital representatives from Thailand and Papua New Guinea to visit the booth, highlighting the global interest in intelligent medical technologies and showcasing the widespread acclaim for ACE Biotek's innovations. ACE Biotek presented two flagship solutions, the EP100 Ophthalmology Recording System (EaglePark100) and the Spark Surgical Anesthesia System. The EP100 focuses on data sharing and collaboration, seamlessly integrating examination rooms with clinics. It enables digitized, structured, and paperless data management, significantly enhancing medical efficiency and precision and benefiting physicians, nurses, and technicians alike. Meanwhile, the Spark Surgical Anesthesia System integrates anesthesia data throughout surgical processes, from physiological monitors to anesthesia machines, ensuring real-time data recording and seamless data flow. It can flexibly integrate with hospital HIS, surgery, and pricing systems while leveraging AI-powered medical big data to improve operational efficiency and accuracy, helping hospitals achieve smarter, standardized surgical management. Steve Hsu, President of ACE Biotek, remarked: "We are honored to collaborate with Shin Kong Wu Ho-Su Memorial Hospital, supporting their ESG sustainability goals with innovative smart healthcare solutions. This exhibition showcases ACE Biotek's leadership in advanced medical technologies and our commitment to fostering partnerships to advance the globalization of smart healthcare." Shin Kong Wu Ho-Su Memorial Hospital remains committed to ESG principles, reducing carbon emissions and setting a benchmark for sustainability within the healthcare industry. By collaborating with ACE Biotek, the hospital is advancing its digital transformation towards a comprehensive smart hospital framework. ACE Biotek will continue innovating and developing cutting-edge smart medical solutions, fostering partnerships to elevate the next generation of healthcare and contributing to the development of green, sustainable smart hospitals. About ACE Biotek Established in 2000, ACE Group has grown for more than 20 years across wireless and healthcare industries. Originally, ACE Group formed ACE Solution as its first foray to focus on wireless communication, networking hardware, and customized system integration projects. Driven by President Steve’s vision to improve healthcare quality, he built the ACE Biotek building from the ground up and officially founded ACE Biotek in 2018. ACE Biotek integrates the past 20 years of industrial experience and knowledge to solve unmet clinical needs. In order to achieve the early diagnosis of diseases, we have developed smart medical solutions regarding imaging algorithms, cloud computing, artificial intelligence, and terahertz technology so far. Long term, ACE Biotek will expand globally to serve as a platform to cultivate talents and support tech companies to transform into Medtech. Contact ACE Biotek Advanced ACE Biotek Co., Ltd.Address: No. 66, Shengyi 2nd Rd., Zhubei City, Hsinchu County 302, Taiwan (Hsinchu Biomedical Science Park)Phone: +886-3-5500909E-mail: service@acebiotek.comWebsite: https://www.acebiotek.com/Facebook: https://www.facebook.com/Acebiotek/LinkedIn: https://www.linkedin.com/company/30620922/admin/
A12 藝術空間
smart hospitals
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
